Goldfinch Bio Obtains $55,000,000 Series A Round

  • Feed Type
  • Date
    12/15/2016
  • Company Name
    Goldfinch Bio
  • Mailing Address
    215 First Street 4th Floor Cambridge, MA 02142 USA
  • Company Description
    At Goldfinch, we are pioneering a new approach to discover and develop therapeutics for kidney disease that is unprecedented.
  • Website
    http://www.goldfinchbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $55,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Third Rock Ventures

Trending on Xconomy